ATLANTA, Sept. 8 /PRNewswire/ -- Elekta is one of the leading supporters of the Rocks Against Cancer benefit to take place September 16 at the Angel Orensanz Foundation for the Arts in New York City. Proceeds from the event will support EIF cancer programs, including Stand Up to Cancer (SU2C), an initiative created to speed the development and deployment of promising new therapies to improve and save patient lives. The celebrity chairperson of Rocks Against Cancer is actor John Lithgow.
"As a human care company, Elekta is honored to support Rocks Against Cancer," says Jay Hoey, Executive Vice President of Elekta North America. "It is only through the medical community and philanthropic outreach that we can complete our mission, which is putting into the hands of healthcare professionals the tools they need to treat cancer and brain disorders, and to improve, prolong and save patient lives."
The first and only freestanding cancer center of its kind in Manhattan, The Farber Center for Radiation Oncology, is hosting the event, as well as serving as a major sponsor.
"Rocks Against Cancer was put together with the same principles for why we started The Farber Center for Radiation Oncology on the most humanistic level," says Leonard A. Farber, M.D., the Center's Founder and Director. "It is about giving back to people and the community, and bringing cancer care to the next level. It is in harmony with Elekta's philosophy, which emphasizes caring for the whole person, not just treating their disease. The most fundamental understanding of the preciousness of life is what has driven us to pursue our dream to help people with cancer—to help them live fuller lives while under our care and ideally once their disease is defeated."
The fundraiser will feature a performance by Eclectic Method, featuring London natives Jonny Wilson, Ian Edgar and Geoff Gamlen, renowned for pioneering the emerging art of audio-visual mixing. The event also includes a silent auction of specially designed bracelets by jeweler to the stars, Stephen Webster. Net proceeds will benefit EIF's cancer programs, including SU2C, Woman's Cancer Research Fund, Brains on Bikes, Right Action for Women and the National Colorectal Research Alliance.
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy and radiosurgery, as well as workflow enhancing software systems across the spectrum of cancer care.
Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives, making the future possible.
Today, Elekta solutions in oncology and neurosurgery are used in over 5,000 hospitals globally, and every day more than 100,000 patients receive diagnosis, treatment or follow-up with the help of a solution from the Elekta Group.
Elekta employs around 2,500 employees globally. The corporate headquarter is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. For more information about Elekta, please visit www.elekta.com.
Copyright©2010 PR Newswire.
All rights reserved